ATE279187T1 - Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen - Google Patents
Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungenInfo
- Publication number
- ATE279187T1 ATE279187T1 AT01940634T AT01940634T ATE279187T1 AT E279187 T1 ATE279187 T1 AT E279187T1 AT 01940634 T AT01940634 T AT 01940634T AT 01940634 T AT01940634 T AT 01940634T AT E279187 T1 ATE279187 T1 AT E279187T1
- Authority
- AT
- Austria
- Prior art keywords
- conjugated
- pharmaceutical composition
- composition containing
- salt
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0007117A FR2809735B1 (fr) | 2000-06-02 | 2000-06-02 | Composition pharmaceutique contenant au moins un polymere associe ou conjugue a au moins un sel d'un acide phenylalkycarboxylique, polymeres conjugues et leurs applications |
| PCT/FR2001/001672 WO2001091742A1 (fr) | 2000-06-02 | 2001-05-30 | Composition pharmaceutique contenant au moins un polymere associe ou conjugue a au moins un sel d'un acide phenylalkylcarboxylique, polymeres conjugues et leurs applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279187T1 true ATE279187T1 (de) | 2004-10-15 |
Family
ID=8850928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01940634T ATE279187T1 (de) | 2000-06-02 | 2001-05-30 | Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20030171333A1 (de) |
| EP (1) | EP1289515B1 (de) |
| JP (1) | JP2003534374A (de) |
| AT (1) | ATE279187T1 (de) |
| CA (1) | CA2410882A1 (de) |
| DE (1) | DE60106436D1 (de) |
| FR (1) | FR2809735B1 (de) |
| WO (1) | WO2001091742A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080161230A1 (en) * | 2004-04-23 | 2008-07-03 | Novexin Limited | Methods and Kits for Stabilising, Protecting and Solubilising Proteins |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| FR2966248B1 (fr) | 2010-10-18 | 2020-05-01 | Centre National De La Recherche Scientifique (Cnrs) | Procede de fonctionnalisation de surfaces pour la detection d'analytes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3793065A (en) * | 1972-03-10 | 1974-02-19 | Owens Corning Fiberglass Corp | Size coated glass fibers |
| DK110188D0 (da) * | 1988-03-02 | 1988-03-02 | Claus Selch Larsen | High molecular weight prodrug derivatives of antiinflammatory drugs |
| FR2657782B1 (fr) * | 1990-02-06 | 1992-05-22 | Therapeutiques Substitutives | Nouvel agent antitumoral derive du dextrane. |
| AU650914B2 (en) * | 1990-11-06 | 1994-07-07 | Fgn, Inc. | Esters and amides of substituted phenyl acetic acids |
| CA2091410A1 (en) * | 1993-03-10 | 1994-09-11 | Thomas C. Usher | Pharmaceutical preparations for the treatment of various viral diseases and cancers |
| WO1995000177A1 (en) * | 1993-06-17 | 1995-01-05 | Dextran Products Limited | Pharmaceutical preparation and a method for inhibiting the replication of various viruses |
-
2000
- 2000-06-02 FR FR0007117A patent/FR2809735B1/fr not_active Expired - Fee Related
-
2001
- 2001-05-30 JP JP2001587758A patent/JP2003534374A/ja active Pending
- 2001-05-30 WO PCT/FR2001/001672 patent/WO2001091742A1/fr not_active Ceased
- 2001-05-30 AT AT01940634T patent/ATE279187T1/de not_active IP Right Cessation
- 2001-05-30 CA CA002410882A patent/CA2410882A1/en not_active Abandoned
- 2001-05-30 US US10/297,035 patent/US20030171333A1/en not_active Abandoned
- 2001-05-30 DE DE2001606436 patent/DE60106436D1/de not_active Expired - Lifetime
- 2001-05-30 EP EP01940634A patent/EP1289515B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030171333A1 (en) | 2003-09-11 |
| EP1289515A1 (de) | 2003-03-12 |
| WO2001091742A1 (fr) | 2001-12-06 |
| EP1289515B1 (de) | 2004-10-13 |
| JP2003534374A (ja) | 2003-11-18 |
| FR2809735B1 (fr) | 2003-08-01 |
| CA2410882A1 (en) | 2001-12-06 |
| DE60106436D1 (de) | 2004-11-18 |
| FR2809735A1 (fr) | 2001-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69017167D1 (de) | Organisches polymer, dessen herstellung und härtbare zusammensetzung, die es enthält. | |
| DK1163274T3 (da) | Fremgangsmåde til tværbinding af hyaluronsyre til polymerer | |
| EP1595884A3 (de) | Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen | |
| ATE551046T1 (de) | Polymere duftkapseln und ihre herstellung | |
| SV1999000048A (es) | Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv | |
| ATE290882T1 (de) | Pharmazeutische mischung gegen krebs, die ein 4- chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält | |
| EP1449857A4 (de) | Polymer auf basis von konjugierten dienen, herstellungsverfahren dafür und dieses enthaltende kautschukzusammensetzungen | |
| ID29534A (id) | Turunan-turunan asam pirazolkarboksilat, pembuatannya, komposisi-komposisi farmasi yang mengandungnya | |
| ATE477301T1 (de) | Bei niedrigen temperaturen flüssige polymere polythioether | |
| DE69915011D1 (de) | Wässrige zusammensetzung, die wasserlösliches oder in wasser dispergierbares synthetisches polymer enthält | |
| BRPI0416114A (pt) | materiais compósitos compreendendo nanopartìculas carregadas com metal | |
| DE60118790D1 (de) | Polymere biomaterialien, die silsesquioxan-monomere enthalten | |
| BR9803198A (pt) | Composto, processos para preparar o mesmo e para combater fungo ou uma doença fúngica de plantas em um local, e, composição. | |
| DE60001728D1 (de) | Infektionsresistente polymere, ihre herstellung und verwendungen | |
| CA2399039A1 (en) | Hyaluronic acid gel, method of its production and medical material containing it | |
| ATE425767T1 (de) | Konjugate von cyanovirin-varianten und einem polyalkylenoxid | |
| ATE435506T1 (de) | Konjugierte polymere, deren darstellung und verwendung | |
| BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
| ATE401875T1 (de) | Pharmazeutische feste dispersionen von modafinil- verbindungen | |
| BR0311700A (pt) | Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula | |
| ES2335410T8 (es) | Derivados de aminopropanol. | |
| EP1668719A4 (de) | 2,7-carbazolenvinylen-derivate als neuartige materialien bei der herstellung organisch basierter elektronischer bauelemente | |
| ATE420099T1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| EP1602672A4 (de) | Propylen-copolymer, zusammensetzung davon und herstellungsverfahren | |
| DE60025639D1 (de) | Substituierte diazepan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |